ライフサイエンスコーパス: recurrent UTI

1 28 (22%) in the placebo group had at least 1 recurrent UTI (difference, -6%; 95% confidence interval

2 elevated urinary calcium excretion (n = 2), recurrent UTI (n = 2), and urinary stasis (n = 2).

3 (0.12 per person-year after first UTI) had a recurrent UTI.

4 entify the risk factors for resistance among recurrent UTIs.

5 is a significant risk factor for chronic and recurrent UTI.

6 iation between antimicrobial prophylaxis and recurrent UTI, and a nested case-control study was perfo

7 iation between antimicrobial prophylaxis and recurrent UTI, and to identify the risk factors for resi

8 d risk factor for chronic pyelonephritis and recurrent UTI in susceptible groups, even if it is outco

9 asymptomatic bacteriuria, to symptomatic and recurrent UTIs, to sepsis associated with UTI requiring

10 s could markedly reduce the rate of UTIs and recurrent UTIs.

11 ecurrence rate among young women affected by recurrent UTI.

12 sylation and invasion of host cells to cause recurrent UTIs.

13 ostridium difficile, significantly decreased recurrent UTI frequency, and improved antibiotic suscept

14 iotic therapy, 30-50% of patients experience recurrent UTIs.

15 are isolated cases, 1 in 40 women experience recurrent UTIs.

16 lysis was used to determine risk factors for recurrent UTI and the association between antimicrobial

17 To identify risk factors for recurrent UTI in a pediatric primary care cohort, to det

18 iotic use is the most effective strategy for recurrent UTI prevention compared to daily cranberry pil

19 ions for the development of therapeutics for recurrent UTI.

20 rative effectiveness strategies for managing recurrent UTIs are lacking.

21 hiasis include retention of suture material, recurrent UTI, hypercalciuria, and urinary stasis.

22 eveloped a Markov chain Monte Carlo model of recurrent UTI for each management strategy with >/=2 ade

23 each additional copy of DEFA1A3, the odds of recurrent UTI in patients receiving antibiotic prophylax

24 illi may be important in the pathogenesis of recurrent UTI by facilitating E. coli introital coloniza

25 ecurrent UTI and antimicrobial resistance of recurrent UTI pathogens.

26 is was not associated with decreased risk of recurrent UTI (HR, 1.01; 95% CI, 0.50-2.02), even after

27 s, factors associated with increased risk of recurrent UTI included white race (0.17 per person-year;

28 substantially without affecting the risk of recurrent UTI or renal scarring.

29 is was not associated with decreased risk of recurrent UTI, but was associated with increased risk of

30 3 copy number did not associate with risk of recurrent UTI.

31 plications for understanding the etiology of recurrent UTIs.

32 may be a previously unappreciated source of recurrent UTIs and (ii) that inducing epithelial exfolia

33 (UT); however, since a significant subset of recurrent UTIs are caused by an identical bacterial stra

34 Patient-initiated treatment of recurrent UTIs may decrease antimicrobial use and improv

35 role of antibiotic prophylaxis in preventing recurrent UTI and renal scarring in young children with

36 membrane-enclosed latent reservoirs to seed recurrent UTI.

37 lar colonization resistance and cause severe recurrent UTI, which could be prevented by cyclooxygenas

38 hildren were monitored for 1 year, and their recurrent UTIs were recorded.

39 increased susceptibility of nonsecretors to recurrent UTI.

40 the basis of understanding susceptibility to recurrent UTI in women.

41 Time to recurrent UTI and antimicrobial resistance of recurrent

42 can accurately self-diagnose and self-treat recurrent UTIs.

43 ltures were obtained from 140 women, 65 with recurrent UTI (case-patients) and 75 without (controls).

44 The presence of IBC/IIB was associated with recurrent UTI (odds ratio [OR], 3.3; 95% confidence inte

45 tibimicrobial resistance among children with recurrent UTI (HR, 7.50; 95% CI, 1.60-35.17).

46 trol study was performed among children with recurrent UTI to identify risk factors for resistant inf

47 d explain a high proportion of children with recurrent UTI.

48 One study of patients with recurrent UTI found that self-diagnosis significantly in

49 Sequential isolates from patients with recurrent UTI were classified, using macrorestriction an

50 ion, low DEFA1A3 copy number associated with recurrent UTIs in subjects in the RIVUR Study randomized

51 es and should be considered in patients with recurrent UTIs.

52 or for prophylaxis for menopausal women with recurrent UTIs.